European regulators have given Roche CE-IVD marking for its Cobas methicillin-resistant Staphylococcus aureus and Staphylococcus aureus nucleic acid test for use on its Liat PCR point-of-care platform. The test, intended for supporting rapid screening and surveillance of MRSA and SA infections in intensive care units, labs and emergency rooms, enables simultaneous MRSA and SA detection using a single sample in under 30 minutes.
EU OKs Roche's MRSA/SA test on Liat PCR system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.